Search Results

There are 34774 results for: content related to: Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus

  1. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy

    Arthritis & Rheumatism

    Volume 41, Issue 5, May 1998, Pages: 831–837, Chi Chiu Mok, Chak Sing Lau and Raymond Woon Sing Wong

    Article first published online : 28 MAY 2004, DOI: 10.1002/1529-0131(199805)41:5<831::AID-ART9>3.0.CO;2-1

  2. Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide

    Arthritis & Rheumatism

    Volume 39, Issue 12, December 1996, Pages: 2028–2034, Elena Ciruelo, Javier de la Cruz, Ignacio López and Juan J. Gómez-reino

    Article first published online : 12 DEC 2005, DOI: 10.1002/art.1780391212

  3. You have free access to this content
    Prevention of renal damage in murine lupus nephritis by CTLA-4Ig and cyclophosphamide

    Arthritis & Rheumatism

    Volume 50, Issue 5, May 2004, Pages: 1539–1548, Gaye Cunnane, Owen T. M. Chan, Gail Cassafer, Seth Brindis, Elizabeth Kaufman, T. S. Benedict Yen and David I. Daikh

    Article first published online : 6 MAY 2004, DOI: 10.1002/art.20147

  4. You have free access to this content
    The cycloidea gene can respond to a common dorsoventral prepattern in Antirrhinum

    The Plant Journal

    Volume 30, Issue 6, June 2002, Pages: 639–648, Jennifer I. Clark and Enrico S. Coen

    Article first published online : 13 JUN 2002, DOI: 10.1046/j.1365-313X.2002.01310.x

  5. You have free access to this content
    Anti–müllerian hormone and ovarian reserve in systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 65, Issue 1, January 2013, Pages: 206–210, C. C. Mok, P. T. Chan and C. H. To

    Article first published online : 27 DEC 2012, DOI: 10.1002/art.37719

  6. Quantum Mechanics/Molecular Mechanics Studies on the Mechanism of Action of Cofactor Pyridoxal 5′-Phosphate in Ornithine 4,5-Aminomutase

    Chemistry - A European Journal

    Volume 20, Issue 36, September 1, 2014, Pages: 11390–11401, Dr. Jiayun Pang, Prof. Nigel S. Scrutton and Prof. Michael J. Sutcliffe

    Article first published online : 22 JUL 2014, DOI: 10.1002/chem.201402759

  7. Cyclophosphamide plasma and cerebrospinal fluid kinetics with and without dimethyl sulfoxide

    Clinical Pharmacology & Therapeutics

    Volume 32, Issue 1, July 1982, Pages: 122–128, Merrill J Egorin, Richard S Kaplan, Michael Salcman, Joseph Aisner, Michael Colvin, Peter H Wiernik and Nicholas R Bachur

    Article first published online : 22 JUL 1982, DOI: 10.1038/clpt.1982.135

  8. You have free access to this content
    Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis

    Arthritis & Rheumatism

    Volume 50, Issue 8, August 2004, Pages: 2559–2568, Chi Chiu Mok, King Yee Ying, Sydney Tang, Chung Ying Leung, Ka Wing Lee, Woon Leung Ng, Raymond Woon Sing Wong and Chak Sing Lau

    Article first published online : 5 AUG 2004, DOI: 10.1002/art.20364

  9. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized study

    Arthritis & Rheumatism

    Volume 41, Issue 10, October 1998, Pages: 1835–1844, M. Haubitz, S. Schellong, U. Göbel, H. J. Schurek, D. Schaumann, K. M. Koch and R. Brunkhorst

    Article first published online : 14 MAY 2004, DOI: 10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q

  10. Induction intravenous cyclophosphamide followed by maintenance oral immunosuppression in refractory myasthenia gravis

    Muscle & Nerve

    Volume 52, Issue 2, August 2015, Pages: 204–210, Katherine A. Buzzard, Nicholas J. Meyer, Todd A. Hardy, D. Sean Riminton and Stephen W. Reddel

    Article first published online : 18 JUN 2015, DOI: 10.1002/mus.24536

  11. You have free access to this content
    Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine

    Arthritis & Rheumatism

    Volume 46, Issue 4, April 2002, Pages: 1003–1013, Chi Chiu Mok, Carmen Tze Kwan Ho, Kwok Wah Chan, Chak Sing Lau and Raymond Woon Sing Wong

    Article first published online : 5 APR 2002, DOI: 10.1002/art.10138

  12. Significance of consensus CYC-binding sites found in the promoters of both ChCYC and ChRAD genes in Chirita heterotricha (Gesneriaceae)

    Journal of Systematics and Evolution

    Volume 48, Issue 4, July 2010, Pages: 249–256, Xia YANG, Hong CUI, Zu-Li YUAN and Yin-Zheng WANG

    Article first published online : 12 JUL 2010, DOI: 10.1111/j.1759-6831.2010.00086.x

  13. Influence of Glomerular Filtration Rate on the Pharmacokinetics of Cyclophosphamide Enantiomers in Patients With Lupus Nephritis

    The Journal of Clinical Pharmacology

    Volume 49, Issue 8, August 2009, Pages: 965–972, Carolina de Miranda Silva, Bruno José Dumêt Fernandes, Eduardo Antônio Donadi, Lucienir Maria Silva, Eduardo Barbosa Coelho, Márcio Dantas, Maria Paula Marques and Vera Lucia Lanchote

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009337938

  14. A New Heteroleptic Ruthenium Sensitizer for Transparent Dye-Sensitized Solar Cells

    Advanced Energy Materials

    Volume 2, Issue 12, December, 2012, Pages: 1503–1509, Chia-Yuan Chen, Nuttapol Pootrakulchote, Min-Yu Chen, Thomas Moehl, Hui-Hsu Tsai, Shaik M. Zakeeruddin, Chun-Guey Wu and Michael Grätzel

    Article first published online : 17 JUL 2012, DOI: 10.1002/aenm.201200285

  15. Floral zygomorphy, the recurring evolution of a successful trait

    BioEssays

    Volume 26, Issue 11, November 2004, Pages: 1175–1184, Pilar Cubas

    Article first published online : 21 OCT 2004, DOI: 10.1002/bies.20119

  16. You have free access to this content
    Treatment for lupus nephritis: A revisit

    Nephrology

    Volume 10, Issue 2, April 2005, Pages: 180–188, KAR NENG LAI, SYDNEY C W TANG and CHI CHIU MOK

    Article first published online : 5 MAY 2005, DOI: 10.1111/j.1440-1797.2005.00372.x

  17. You have free access to this content
    Expression pattern of CYC-like genes relating to a dorsalized actinomorphic flower in Tengia (Gesneriaceae)

    Journal of Systematics and Evolution

    Volume 48, Issue 5, September 2010, Pages: 309–317, Hong-Bo PANG, Qing-Wen SUN, Shun-Zhi HE and Yin-Zheng WANG

    Article first published online : 26 SEP 2010, DOI: 10.1111/j.1759-6831.2010.00091.x

  18. You have free access to this content
    Anti-Müllerian hormone: A better marker of ovarian damage from cyclophosphamide

    Arthritis & Rheumatism

    Volume 64, Issue 5, May 2012, Pages: 1305–1310, Megan E. B. Clowse, Lindsey Harward, Lisa Criscione-Schreiber, David Pisetsky and Susannah Copland

    Article first published online : 26 APR 2012, DOI: 10.1002/art.34431

  19. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis a 20-year followup study

    Arthritis & Rheumatism

    Volume 38, Issue 8, August 1995, Pages: 1120–1127, Charles D. Radis, Leslie E. Kahl, Gary L. Baker, Mary Chester Morgan Wasko, Joseph M. Cash, Aileen Gallatin, Bertrand L. Stolzer, Amrit K. Agarwal, Thomas A. Medsger Jr and C. Kent Kwoh

    Article first published online : 9 DEC 2005, DOI: 10.1002/art.1780380815

  20. Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome

    Pediatrics International

    Volume 45, Issue 1, February 2003, Pages: 65–67, ZELAL BİRCAN and BÜLENT KARA

    Article first published online : 11 APR 2003, DOI: 10.1046/j.1442-200X.2003.01673.x